检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:吴素兰 毛剑波 沈丽君 林丽 陈亦棋 张赟 陶继伟 张彩云 邵伊润 Su-Lan Wu;Jian-Bo Mao;Li-Jun Shen;Li Lin;Yi-Qi Chen;Yun Zhang;Ji-Wei Tao;Cai-Yun Zhang;Yi-Run Shao(Eye Fundus Center,the Affiliated Eye Hospital of Wenzhou Medical University,Hangzhou 310000,Zhejiang Province,China)
机构地区:[1]温州医科大学附属眼视光医院杭州院区眼底病中心
出 处:《国际眼科杂志》2020年第2期350-353,共4页International Eye Science
基 金:温州市科技计划项目(No.Y20190649)~~
摘 要:目的:观察玻璃体腔注射康柏西普联合周边视网膜激光治疗缺血型视网膜静脉阻塞继发黄斑水肿(RVO-ME)的疗效。方法:回顾性病例研究。收集2014-10/2018-11在温州医科大学附属眼视光医院诊断为缺血型RVO-ME的患者39例39眼,其中CRVO患者14例14眼,BRVO患者25例25眼。所有患者均予玻璃体腔注射康柏西普联合周边视网膜激光光凝治疗。分别于治疗前后检测最佳矫正视力(BCVA)和黄斑中心凹厚度(CMT)。结果:治疗后1、2、3、6mo,本组患者BCVA(0.67±0.49、0.56±0.41、0.62±0.52、0.47±0.40)均较治疗前(0.99±0.57)显著改善(P <0.05),CMT (299.5±188.1、254.8±127.6、294.1±174.9、228.8±64.45μm)均较治疗前(608.4±214.7μm)显著下降(P<0.05)。治疗后6mo BCVA与治疗前基线BCVA呈正相关(r=0.78,P<0.05),而与治疗前CMT无明显相关性(r=0.25,P=0.13)。结论:玻璃体腔注射康柏西普联合周边视网膜激光光凝治疗缺血型RVO-ME疗效确切,可有效改善视力,降低CMT。·AIM:To investigate the effects of intravitreal conbercept combined with peripheral laser photocoagulation for ischemic RVO-ME.·METHODS:A retrospective clinical study.Totally 39 patients(39 eyes) were included in this study since 2014-10 to 2018-11,who were diagnosed ischemic RVO-ME in Eye Hospital of Wenzhou Medical University.There were14 CRVO and 25 BRVO.All patients were given intravitreal conbercept combined with peripheral laser photocoagulation.BCVA,OCT were examined before and after treatment.·RESULTS:BCVA of 1,2,3,6 mo(0.67±0.49,0.56±0.41,0.62±0.52,0.47±0.40) after treatment was significantly improved compared to base line(0.99±0.57)(P<0.05).CMT of 1,2,3,6 mo(299.5±188.1,254.8±127.6,294.1±174.9,228.8±64.45μm) after treatment was significantly decreased compared to base line(608.4±214.7μm)(P<0.05).BCVA of 6 mo was positively correlated with base line BCVA(r=0.78,P <0.05),while there was no correlation with base line CMT(r=0.25,P=0.13).·CONCLUSION:Intravitreal conbercept combined with peripheral laser photocoagulation is a effective approach for ischemic RVO-ME,which can significantly improve BCVA and decrease CMT.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15